Basics Enliven Therapeutics, Inc. IPO Date: February 24, 2023 Sector: Healthcare Industry: Biotech Market Cap: $1.29B Activated in VL: True Average Daily Range Avg Daily Range: $0.60 | 3.15% Avg Daily Range (30 D): $0.70 | 3.33% Avg Daily Range (90 D): $0.56 | 2.74% Institutional Daily Volume Avg Daily Volume: .22M Avg Daily Volume (30 D): .49M Avg Daily Volume (90 D): .42M Trade Size Avg Trade Size (Sh.): 65 Avg Trade Size (Sh.) (30 D): 66 Avg Trade Size (Sh.) (90 D): 63 Institutional Trades Total Inst.Trades: 685 Avg Inst. Trade: $1.48M Avg Inst. Trade (30 D): $1.35M Avg Inst. Trade (90 D): $1.37M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.4M Avg Closing Trade (30 D): $1.04M Avg Closing Trade (90 D): $1.17M Avg Closing Volume: 66.45K     News Aug 13, 2025 @ 10:15 PM Enliven Posts Loss Beat and Cash Surge Source: Jesterai Oct 14, 2024 @ 7:05 PM Enliven Therapeutics, Inc. Is a Great Choice for '... Source: Zacks Sep 28, 2024 @ 1:35 PM Enliven Therapeutics Announces Positive Data Updat... Source: N/A Jul 16, 2024 @ 10:44 PM Enliven Therapeutics COO sells over $1.25m in comp... Source: Investing.Com May 29, 2024 @ 8:05 PM Enliven Therapeutics to Present at Two Upcoming In... Source: Enliven Therapeutics, Inc. Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.81 $-.32 Diluted EPS $-1.81 $-.32 Revenue $ M $ M $ Gross Profit $ $ $ Net Income / Loss $ -97.21M $ -20.15M $ -25.34M Operating Income / Loss $ -112.27M $ -25.1M $ Cost of Revenue $ $ $ Net Cash Flow $ 1.06M $ $ PE Ratio